Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA advisory committee OKs safety and efficacy of Rapamune

July 28, 1999

Eligix cleared to initiate pivotal trial of DLI purification technology

July 28, 1999

AHP's pneumococcal conjugate vaccine receives priority review status

July 27, 1999

ProdiGene patents edible vaccines

July 23, 1999

Inhibitors of Src family SH2 domains in early-stage development at Boehringer Ingelheim

July 22, 1999

Novartis exercises option to license complement inhibitor from Avant

July 21, 1999

Rotavirus vaccine temporarily suspended due to reports of intussusception

July 20, 1999

Takeda patents inhibitors of ICAM-1/ELAM-1 expression for immune, autoimmune disorders

July 20, 1999

Cantab's therapeutic vaccine for genital warts enters phase II trials

July 20, 1999

New topical ciclosporin formulation effective for site-specific immunosuppression

July 20, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...